2024 Biopharma Investment Outlook with Chris Dokomajilar

from Rx for Biotech · host Podcast Host Chris Leidli

Our guest in this podcast episode is Chris Dokomajilar, Founder and CEO of DealForma. DealForma’s comprehensive life science database includes meticulously researched licensing deal financial comps, up-to-date profiles, and historic company and pipeline data. In this special spotlight episode, we take a deeper dive into the investment landscape for advanced therapies and also AI investment and partnership activity in the biopharma space.

Episode metadata supplied by the publisher feed · Published Feb 12, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

2024 Biopharma Investment Outlook with Chris Dokomajilar

0:00 19:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 19 minutes long.

When was this Rx for Biotech episode published?

This episode was published on February 12, 2024.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!